The Newsroom

GLP-1 News & Analysis

What GLP-1 weight-loss medicines cost, how they compare and what the FDA has changed, checked against the labels, the trials and each program's own price pages.

Ready to pick one? Take the 2-minute match quiz or see the cheapest options.

Start here

Choose the question you want to answer first.

Looking for your state? Browse state coverage guides

Latest

What it costs and who pays

Monthly prices, up-front payments, insurance, Medicare, HSA and FSA.

All 6 in Cost & Insurance

GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)

Without insurance, brand GLP-1s cost $149 to $499 a month direct from the makers: Foundayo and the Wegovy pill from $149, Zepbound from $299, and the Wegovy pen $199 for the first two low-dose fills, then $349. If your commercial plan covers the drug, a savings card can bring it to $25. On Medicare, the GLP-1 Bridge charges $50 a month if you qualify.

JULY 6, 2026

11 min read

Does Medicare Cover Wegovy, Zepbound or Ozempic for Weight Loss in 2026?

Yes for Wegovy and the Zepbound KwikPen, if you qualify: the Medicare GLP-1 Bridge covers them for weight management at $50 a month. Ozempic is not in the Bridge, and basic Part D does not pay for it solely for weight loss. Check the exact drug, form and reason it is prescribed before you pay.

JULY 6, 2026

8 min read

Ozempic for PCOS (2026): Evidence, Coverage and Cost

Ozempic is not FDA-approved for PCOS. It is approved for type 2 diabetes. The 2023 international PCOS guideline says semaglutide may be considered, alongside active lifestyle intervention, for weight management in adults with PCOS and higher weight under general-population criteria. That is different from an approval to treat PCOS or infertility. Coverage depends on the prescribed product, approved indication, plan formulary and prior-authorization rules. This guide separates the evidence from the labels, then compares realistic coverage and cash-pay paths.

JUNE 24, 2026

11 min read

Compounded Semaglutide After the Shortage: FDA Enforcement and Switch Options

FDA resolved the semaglutide shortage on February 21, 2025. Temporary shortage-based enforcement discretion ended after an April 24 court decision for 503A pharmacies and on May 22 for 503B facilities. This guide separates those dates from FDA's pending 503B bulk-list proposal and compares paths to discuss with a prescriber.

JUNE 19, 2026

13 min read

Is Compounded Tirzepatide Legal and Safe? FDA Rules and What Changed in 2026

It depends on the pharmacy and the prescription. Tirzepatide's shortage ended in October 2024, the broad shortage pathway for compounding closed in early 2025, and FDA has not reviewed compounded tirzepatide for safety or quality. Programs still sell it. Here is what each charges, what the law requires and what to check before you pay.

APRIL 11, 2026

13 min read

Which medicine fits you

Two drugs side by side: price, how you take it and what the trials found.

All 7 in Comparisons

Foundayo vs Wegovy Pill: Which Is Cheaper and What Differs (2026)

Foundayo and the Wegovy pill both cost $149 a month at the starting dose. After that, the Wegovy pill costs $199 at 4 mg and $299 at 9 or 25 mg, while Foundayo stays at $149 at 2.5 mg and $199 at 5.5 mg through December 31, 2026. We checked both makers' prices on October 16, 2026.

JULY 16, 2026

20 min read

Semaglutide vs Tirzepatide: Weight Loss, Side Effects and Cost

Tirzepatide caused more weight loss than semaglutide in the SURMOUNT-5 trial: 20.2% against 13.7% over 72 weeks, in adults with obesity without diabetes. Both cause similar stomach side effects. Without insurance, Zepbound starts at $299 a month from LillyDirect, and the Wegovy pen costs $199 for the first two low-dose fills, then $349.

JULY 15, 2026

11 min read

Ozempic vs Wegovy (2026): Uses, Doses, Pills and Injection Costs

Ozempic and Wegovy contain semaglutide, but their labeled uses, doses and formulations differ. Both brands have injection and tablet presentations. Compare the exact product, indication, supply and payment route; do not transfer dose or coverage assumptions between them.

JULY 2, 2026

18 min read

Mounjaro vs Ozempic: Weight Loss, Diabetes and Costs

Mounjaro and Ozempic are different diabetes medicines. Tirzepatide produced greater average weight loss in specific trials, but the widely quoted 20.2% versus 13.7% result studied weight-management doses in adults without diabetes. Here is how that changes the comparison.

JUNE 24, 2026

11 min read

Wegovy Pill vs Injection: Results, Dosing and Real Costs

The Wegovy pill costs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 or 25 mg. The pen costs $199 for the first two low-dose fills, then $349 at standard strengths (prices checked September 20, 2026). You take the pill daily on an empty stomach and the pen once a week, and their results come from separate trials, not a head-to-head test.

APRIL 11, 2026

11 min read

How to start, switch and stay on track

Practical guides for your first months, changing providers and travel.

All 8 in Guides

How to Switch GLP-1 Providers: Records, Refills and Fees

To switch GLP-1 providers, have the new clinician review your care and confirm the prescription and pharmacy before you cancel the old plan. Three programs, Collective, Embody and TrimRx, say in public that their prescriber can continue your current dose if a clinician approves. Your dose, supply and prepaid balance do not carry over automatically.

SEPTEMBER 19, 2026

8 min read

Ozempic Plateau: Why You Stopped Losing Weight

A weight plateau on semaglutide or tirzepatide has four separate causes, and they do not share an answer. Here is how to tell which one you are looking at, using what the STEP and SURMOUNT trials actually measured.

AUGUST 2, 2026

9 min read

Semaglutide Before and After: Weight Loss Results by Month

In STEP 1, weekly semaglutide 2.4 mg plus lifestyle intervention produced 14.9% mean weight loss at 68 weeks. Trial endpoints, dose escalation and withdrawal studies explain what these averages can and cannot tell you about your own timeline.

JULY 17, 2026

12 min read

GLP-1 Receptor Agonists for Weight Loss 2026: FDA-Approved Options, Cost & Prescription Guide

Five GLP-1 medicines are FDA-approved for weight loss: Wegovy injection, the Wegovy pill, Zepbound, Foundayo and Saxenda. You generally qualify with a BMI of 30 or more, or 27 or more with a weight-related condition. In trials, Wegovy injections averaged 14.9% weight loss and Zepbound up to 20.9%. Here is who qualifies, what each option costs and how to get a prescription.

APRIL 13, 2026

12 min read

Side effects and safety

What the labels say, what to watch for and when to call your doctor.

All 3 in Side Effects & Safety

Foods to Avoid on GLP-1: Adjust Meals Without Blanket Bans

Greasy meals can be harder to tolerate on a GLP-1, but there is no list of banned foods. Smaller, slower, lower-fat meals may help with nausea. Here is what to change for each symptom, and when to call your clinician instead.

APRIL 11, 2026

7 min read

News and drugs in trials

FDA decisions, supply changes and the medicines that are not on sale yet.

All 5 in News & Pipeline

Saxenda Is Being Discontinued in January 2027: What Is Actually Ending, and What Switching Really Costs You

Yes. Novo Nordisk is discontinuing Saxenda, with last shipments to wholesalers in late January 2027, and says the decision is not about safety or quality. Victoza stays on the market, and so do the Hikma, Meitheal and Teva-distributed generic liraglutide lines. The US prescribing information we reviewed for Saxenda, Wegovy and Zepbound does not provide a dose conversion from Saxenda to Wegovy or Zepbound, so plan any switch with your prescriber.

AUGUST 27, 2026

10 min read

Featured Partners

Affiliate partners we feature. We may earn a commission.

Embody

Embody illustration of a compounded semaglutide injection vial
from $49/mo·Compounded

Collective

Collective provider illustration of compounded semaglutide injection vial
from $59/mo + $199/year membership after 21 days·Compounded

Gala

Current program options·Brand & Compounded

Check the medication, commitment and total price for your selected plan.

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.